Cresco Labs (CSE: CL) (OTCQX: CRLBF) - Investor Dashboard


➔ Cresco Labs
CSE Ticker: CL
OTCQX Ticker: CRLBF
Market Focus: United States
Classification: Vertically Integrated
Country: United States
Employees: >1400 as of May 2020
Established: 2013
CEO: Charles Bachtell

Cresco Labs – Management Team


Charles Bachtell
CEO
Charles Bachtell – CEO Charles Bachtell is the CEO of Cresco Labs, LLC. Bachtell is an attorney and brings with him deep legal expertise in both corporate governance and complex regulatory compliance. Bachtell lead the efforts for Cresco to the win seven licenses that it currently holds and continues to work to ensure that Cresco remains an industry leader. Bachtell is a founding member of the Illinois Cannabis Bar Association and the Medical Cannabis Alliance of Illinois. Prior to Cresco Labs, Bachtell served for eight years as the Executive Vice President and General Counsel of Guaranteed Rate. Bachtell has established himself as one of the industry’s foremost authorities on regulatory affairs and compliance in one of the nation’s most heavily regulated industries.

Tom Manning
Chair of the Board and Executive Chair
Tom Manning has been a member of the Cresco Labs board since 2016. He was elected the Chair of the Board in 2019 and assumed the role of Executive Chair in 2020. Manning’s past experience includes serving as CEO and Chairman of Dun & Bradstreet and as CEO of Cerberus Asia Operations & Advisory Limited. Manning has deep experience in capital markets, organizational development and corporate strategy.

Robert Sampson
Co-Founder and Director

Prior to forming Cresco Labs, Robert Sampson had more than 20 years of operating experience in large business, including 12 years in the heavily regulated mortgage industry, having served as Chief Operating Officer at Guaranteed Rate, the nation’s seventh largest retail mortgage bank. As the former COO of Cresco Labs, Sampson oversaw the construction of two 40,000 sqft cement precast structures and one 30,000 sqft hybrid greenhouse structure and was responsible for all facility operations and systems. Sampson is currently the CEO of Bemortgage based in Chicago.

Dennis Olis
CFO
Dennis Olis has extensive experience in financial planning, accounting, internal audit, operations and M&A. Before joining Cresco, Olis served as the CFO for Allscripts Healthcare Solutions. In this position, he was responsible for the company’s financial strategy, and he oversaw the $185 million acquisition of McKesson’s healthcare business.

Dominic Sergi
Co-Founder and Director
Dominic Sergi is a highly successful real estate, business and financial expert who devotes much of his free time raising funds to help patients fighting leukemia and lymphoma. As president and chief executive officer of a Chicago-based investment real estate company, Sergi draws on his strategic and business acumen to deliver on the company’s long-term vision and provide asset budgeting forecasts, which have exceeded $120 million in value. Sergi’s many other responsibilities as leader of a growing firm include oversight of all operations and personnel management. Sergi is active in a number of community and charitable organizations and is passionate about giving back to the community.

Mo Dastagir
CIO
In his role as CIO, Mo Dastagir is responsible for overseeing the company’s technological infrastructure and implementing technological systems. Prior to joining Cresco, Dastagir was the Vice President and Chief Technology Officer at Sears Holding Corporation. In this role, he was responsible for managing the technology programs of Sears Home Services Business. His past experience also includes leadership roles with Novartis Pharmaceuticals, Roche Pharmaceuticals, and Amazon Hyderabad.

David Ellis
COO
David Ellis is the current Executive Vice President of Operations for Cresco Labs. Ellis brings a decade of executive level operations experience across several industries to the Cresco Labs team. Most recently, Ellis founded and served as the President and CEO of Greens & Gills, a 10,000 square foot, controlled environment, hydroponic and aquaponic farm on the South Side of Chicago. Through operational best practices and proprietary software, Ellis was able to build one of the only profitable urban farming businesses in the country.

Greg Butler
Chief Commercial Officer

Greg Butler is the company’s first Chief Commercial Officer. He has a background in brand growth, consumer packaged goods, and capital management. Butler has previously worked with companies including Molson Coors, Johnson & Johnson, Pfizer, and Walgreens. As Chief Commercial Officer, he will focus on Cresco Labs’ commercial strategic planning.

Angie Demchenko
Chief People Officer

Angie Demchenko joined Cresco Labs as its first Chief People Officer. Previously, she served as the Vice President, Head of Human Resources at Starwood Retail Partners. In her current role, Demchenko is responsible for employee benefits, recruitment, compensation and performance management.

Jason Erkes
Chief Communications Officer

Jason Erkes is the company’s first Chief Communications Officer. He served Cresco as a consultant for a number of years before officially joining the team. Erkes is a former Emmy-winning journalist and entrepreneur.

Significant Insider Ownership


Charles  Bachtell, CEO:
15.7 million shares

Joe Caltabiano, Former President:
17.6 million shares

Ken Amann, CFO:
1.6 million shares

Dominic Sergi, Director:
11.3 million shares

Robert Sampson, Director:
13.1 million shares

Randy Podolsky, Director:
1.0 million shares

Gerald Corcoran, Director:
1.0 million shares


Visit Cresco Labs, Inc.
at www.crescolabs.com.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Cresco Labs, Inc. is a client of NCV Media, LLC. Read our full disclaimer.